Anti-VEGF Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions

COMMENTED

Blindness and Vision Impairment

Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

J Clin Med

Tomita Y, Lee D, Tsubota K, Negishi K, Kurihara T

doi: 10.3390/jcm10204666

Macular DiseasesRetinal Diseases

Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study

Clin Ophthalmol.

Kulikov AN, Sosnovskii SV, Berezin RD, Maltsev DS, Oskanov DH, Gribanov NA

doi: 10.2147/OPTH.S146019.

COMMENTED

Macular Diseases

Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting

Am J Ophthalmol.

Maggio E, Sartore M, Attanasio M, Maraone G, Guerriero M, Polito A, Pertile G

doi: 10.1016/j.ajo.2018.08.004.

COMMENTED

Macular Diseases

Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD

Sci Rep.

Reid CA, Nettesheim ER, Connor TB, Lipinski DM

doi: 10.1038/

Retinal Diseases

ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical Trials

Retina.

Bressler NM, Beaulieu WT, Bressler SB, Glassman AR, Melia BM, Jampol LM, Jhaveri CD, Salehi-Had H, Velez G, Sun JK, DRCR Retina Network.

doi: 10.1097/IAE.0000000000002633.

Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology

Ophthalmology.

VanderVeen DK, Melia M, Yang MB, Hutchinson AK, Wilson LB, Lambert SR

doi: 10.1016/

Retinal DiseasesFurther Publications

Real-world visual outcomes of laser and anti-VEGF treatments for retinopathy of prematurity

Am J Ophthalmol

Gundlach BS, Kokhanov A, Altendahl M, Suh SY, Fung S, Demer J, Pineles S, Khitri M, Chu A, Tsui I

doi: 10.1016/j.ajo.2021.11.015

COMMENTED

Retinal Diseases

ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION

Retina.

Bonnin S, Dupas B, Lavia C, Erginay A, Dhundass M, Couturier A, Gaudric A, Tadayoni R

doi: 10.1097/IAE.

Retinal Diseases

Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis

Acta Ophthalmol

Fallico M, Maugeri A, Lotery A, Longo A, Bonfiglio V, Russo A, Avitabile T, Pulvirenti A, Furino C, Cennamo G, Barchitta M, Agodi A, Reibaldi M

doi: 10.1111/aos.14681

Related content

Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy

Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study

Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting

Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD

ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical Trials

Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology

Real-world visual outcomes of laser and anti-VEGF treatments for retinopathy of prematurity

ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION

Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis